A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis: Single Centre, Phase 2 Trial
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2012
At a glance
- Drugs Lamotrigine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 13 Apr 2010 Results were presented at the 62nd Annual Meeting of the American Academy of Neurology.
- 09 Sep 2009 Results have been presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
- 12 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.